Inotiv, Inc. — Director's Dealing 2020

May 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-05-19

Reporting Person: Taylor Beth (VP- Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-19	Common Shares	P	5067	$4.38	Acquired	5067	Direct
2020-05-20	Common Shares	P	4933	$4.42	Acquired	10000	Direct
2020-05-21	Common Shares	P	3300	$4.52	Acquired	13300	Direct

Footnotes

F1: The prices reported in column 4 are weighted average prices. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.39, inclusive with respect to the shares purchased on May 19, 2020, $4.22 to $4.81, inclusive with respect to the shares purchased on May 20, 2020, and $4.39 to $4.74, inclusive with respect to the shares purchased on May 21, 2020. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.